Summary
Cardiac hypertrophy is an independent risk factor for sudden cardiac death in clinical settings and the incidence of sudden cardiac death and ventricular arrhythmias are closely related. The aim of this study was to determine the effects of the calmodulin-dependent protein kinase (CaMK) II inhibitor, KN-93, on L-type calcium current (ICa, L) and early after-depolarizations (EADs) in hypertrophic cardiomyocytes. A rabbit model of myocardial hypertrophy was constructed through abdominal aortic coarctation (LVH group). The control group (sham group) received a sham operation, in which the abdominal aortic was dissected but not coarcted. Eight weeks later, the degree of left ventricular hypertrophy (LVH) was evaluated using echocardiography. Individual cardiomyocyte was isolated through collagenase digestion. Action potentials (APs) and ICa, L were recorded using the perforated patch clamp technique. APs were recorded under current clamp conditions and ICa, L was recorded under voltage clamp conditions. The incidence of EADs and Ica, L in the hypertrophic cardiomyocytes were observed under the conditions of low potassium (2 mmol/L), low magnesium (0.25 mmol/L) Tyrode’s solution perfusion, and slow frequency (0.25–0.5 Hz) electrical stimulation. The incidence of EADs and Ica, L in the hypertrophic cardiomyocytes were also evaluated after treatment with different concentrations of KN-92 (KN-92 group) and KN-93 (KN-93 group). Eight weeks later, the model was successfully established. Under the conditions of low potassium, low magnesium Tyrode’s solution perfusion, and slow frequency electrical stimulation, the incidence of EADs was 0/12, 11/12, 10/12, and 5/12 in sham group, LVH group, KN-92 group (0.5 μmol/L), and KN-93 group (0.5 μmol/L), respectively. When the drug concentration was increased to 1 μmol/L in KN-92 group and KN-93 group, the incidence of EADs was 10/12 and 2/12, respectively. At 0 mV, the current density was 6.7±1.0 and 6.3±0.7 PA·PF−1 in LVH group and sham group, respectively (P>0.05, n=12). When the drug concentration was 0.5 μmol/L in KN-92 and KN-93 groups, the peak ICa, L at 0 mV was decreased by (9.4±2.8)% and (10.5±3.0)% in the hypertrophic cardiomyocytes of the two groups, respectively (P>0.05, n=12). When the drug concentration was increased to 1 μmol/L, the peak ICa, L values were lowered by (13.4±3.7)% and (40±4.9)%, respectively (P<0.01, n=12). KN-93, a specific inhibitor of CaMKII, can effectively inhibit the occurrence of EADs in hypertrophic cardiomyocytes partially by suppressing ICa, L, which may be the main action mechanism of KN-93 antagonizing the occurrence of ventricular arrhythmias in hypertrophic myocardium.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Zhang T, Brown JH. Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovasc Res, 2004,63(3):476–486
Anderson ME. Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias. Pharmacol Ther, 2005,106(1):39–55
Li Y, Ma J, Xiao JM, et al. Heterogeneity of action potential and ion currents in the left ventricular myocytes of the rabbit. Acta Physiologica Sinica, 2002,54(5):369–374
Gillis AM, Geonzon RA, Mathison HJ, et al. The effects of barium, dofetilide and 4-aminopyndine (4-AP) on ventricular repolarization in normal and hypertrophied rabbit heart. J Pharmacol Exp Ther, 1998,285(1):262–270
Jafary FH. Devereux formula for left ventricular mass-be careful to use the right units of measurement. J Am Soc Echocardiogr, 2007,20(6):783–791
Fu LY, Wang F, Chen XS, et al. Perforated patch recording of L-type calcium current with β-escin in guinea pig ventricular myocytes. Acta Pharmacol Sin, 2003,24(11):1094–1098
Fan JS, Palade P. Perforated patch recording with beta-escin. Pflügers Arch, 1998,436(6):1021–1023
Sala M, Coppa F, Cappucciati C, et al. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes. Curr Opin Investig Drugs, 2006,7(3): 256–263
Tanskanen AJ, Greenstein JL, O’Rourke B, et al. The role of stochastic and modal gating of cardiac L-type Ca2+ channels on early after-depolarizations. Biophys J, 2005,88(1):85–95
Thomas G, Gurung IS, Killeen MJ, et al. Effects of L-type Ca2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the Scn5a gene modelling human long QT syndrome. J Physiol, 2007,578 (Pt 1):85–97
Qi X, Yeh YH, Chartier D, et al. The calcium/calmodulin/kinase system and arrhythmogenic afterdepolarizations in bradycardia-related acquired long-QT syndrome. Circ Arrhythm Electrophysiol, 2009,2(3): 295–304
Anderson ME. QT interval prolongation and arrhythmia: an unbreakable connection? J Intern Med, 2006,259(1): 81–90
Wu Y, Temple J, Zhang R, et al. Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Circulation, 2002,106(10):1288–1293
Anderson ME. Calmodulin kinase and L-type calcium channels: A recipe for arrhythmias? Trends Cardiovasc Med, 2004,14(4):152–161
Ai X, Curran JW, Shannon TR, et al. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ Res, 2005,97(12): 1314–1322
Author information
Authors and Affiliations
Corresponding author
Additional information
This project was supported by grants from the Fujian Provincial Natural Science Foundation of China (No. 2008J0075) and the Fujian Provincial Science and Technology Project of China (No. 2010Y0011).
Rights and permissions
About this article
Cite this article
Ke, J., Chen, F., Zhang, C. et al. Effects of calmodulin-dependent protein kinase II inhibitor, KN-93, on electrophysiological features of rabbit hypertrophic cardiac myocytes. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 32, 485–489 (2012). https://doi.org/10.1007/s11596-012-0084-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-012-0084-9